Autologous Cytokine Induced Killer Cells (CIK) for Chronic Myeloid Leukemia (CML) Patients on Standard Drug Therapy
Clinical trial NCT00815321 · COMPLETED
Trial details
- NCT number
- NCT00815321
- Sponsor
- Singapore General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2011-11-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.